No abstract available
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Carcinoma, Hepatocellular / drug therapy*
-
Carcinoma, Hepatocellular / mortality
-
Carcinoma, Hepatocellular / pathology
-
Drug Resistance, Multiple / genetics*
-
Drug Resistance, Neoplasm
-
Drug Screening Assays, Antitumor
-
Female
-
Genes, MDR / genetics*
-
Humans
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / mortality
-
Liver Neoplasms / pathology
-
Male
-
Neoplasm Staging
-
Prognosis
-
Risk Assessment
-
Survival Analysis
-
Treatment Outcome
-
Tumor Necrosis Factor-alpha / administration & dosage
Substances
-
Tumor Necrosis Factor-alpha